l carnitine tmao nature medicine 2013 koeth Dietary allicin reduces transformation of L-carnitine to through impact on gut microbiota γ–Butyrobetaine is a pro-atherogenic intermediate
Butyrobetaine is a pro atherogenic intermediate in gut microbial metabolism of L carnitine to TMAO PMC Advances in Clinical and Experimental Medicine l carnitine tmao nature medicine 2013 koeth Non lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis: Innovative carnitine fed rats model reveals resveratrol butyrate Ester's multimechanistic role in reducing TMAO and cardiovascular risk ScienceDirect A Multi omic Association Study of Trimethylamine N Oxide ScienceDirect Intestinal microbiota metabolism of L carnitine, a nutrient in red meat, promotes atherosclerosis PMC
Pay in 4 interest-free payments of $5.39 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5





